11 withdrawn. 11 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 11 | Withdrawn 11 |
Follow Lymphoproliferative Disorders: new trials by email Literature Review of Lymphoproliferative Disorders trials Research Report on Lymphoproliferative Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Antimicrobial Revision in Persistent Febrile Neutropenia Meropenem, Micafungin - Febrile Neutropenia | Phase 4 | Withdrawn | Wake Forest University Health Sciences | 2024-08-01 | 2024-09-19 | |
| A Multicenter In-class Transition Study of Ixazomib Combined With Pomalidomide and Dexamethasone or With Lenalidomide and Dexamethasone in Adults With Relapsed/Refractory Multiple Myeloma Ixazomib, Pomalidomide, Lenalidomide - Multiple Myeloma | Phase 4 | Withdrawn | Takeda | 2022-06-30 | 2022-05-03 | |
| Effect of Standard of Care Reduced Dose Versus Full Dose Buprenorphine/Naloxone in the Perioperative Period on Pain Control and Post-Operative Opioid Use Disorder Symptoms Buprenorphine/naloxone - Opioid-use Disorder, Opioid Use Disorder, Mild | Phase 4 | Withdrawn | Massachusetts General Hospital | 2019-10-01 | 2025-12-31 | |
| ACTHAR Therapy for Central Nervous System Sarcoidosis Repository Corticotropin Injection - Sarcoidosis | Phase 4 | Withdrawn | The Cleveland Clinic | 2019-02-01 | 2020-11-20 | |
| A Study of Treatment ALK(+) Systemic Anaplastic Large Cell Lymphoma With Crizotinib crizotinib - Systemic Anaplastic Large-Cell Lymphoma | Phase 4 | Withdrawn | Jun Zhu | 2015-07-01 | 2016-12-30 | |
| Cardiac Sarcoidosis Response To Steroids Trial Prednisone - Cardiac Sarcoidosis, Sarcoidosis | Phase 4 | Withdrawn | Ottawa Heart Institute Research Corporation | 2014-04-01 | 2013-10-30 | |
| Evolution of Bone Mineral Density (BMD) in Patients With Lymphoma Undergoing Chemotherapy Bone densitometry. - Lymphoma, Osteoporosis | Phase 4 | Withdrawn | Centre Hospitalier Universitaire, Amiens | 2013-04-01 | 2016-12-05 | |
| Evaluation of Vertebral Compression Fracture Fixation With RF Kyphoplasty in Patients With Multiple Myeloma Kyphoplasty/Vertebral Augmentation (Device-StabiliT) - Multiple Myeloma, Compression Fracture of Vertebral Column | Phase 4 | Withdrawn | DFINE Inc. | 2011-05-01 | 2017-01-20 | |
| Valganciclovir to Treat HHV-8 Associated Multicentric Castleman's Disease Valganciclovir - Giant Lymph Node Hyperplasia | Phase 4 | Withdrawn | University of Washington | 2008-12-01 | 2017-04-18 | |
| Evaluating The Impact Of Donepezil Hydrochloride (Aricept) On Behavioral And Psychological Symptoms In Patients With Severe Alzheimer's Disease Donepezil Hydrochloride (Aricept) - Severe Alzheimer's Disease | Phase 4 | Withdrawn | Eisai Inc. | 2008-01-01 | 2012-12-10 | |
| Open-label Study, to Evaluate the Safety and Tolerability of Zoledronic Acid in Patients With Bone Lesions Secondary to Multiple Myeloma. Zoledronic acid - Multiple Myeloma | Phase 4 | Withdrawn | Novartis | 2004-04-01 | 2015-04-14 |
Multiple Myeloma (3) · Lymphoma, Follicular (2) · Sarcoidosis (2) · Alzheimer Disease (1) · Back Pain (1) · Castleman Disease (1) · Febrile Neutropenia (1) · Leukemia, Myeloid, Acute (1) · Lymphoma (1) · Lymphoma, Large-Cell, Anaplastic (1) · Neoplasms (1) · Opioid-Related Disorders (1) · Osteoporosis (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)
Hemic and Lymphatic Diseases (11) · Immune System Diseases (11) · Immunoproliferative Disorders (9) · Lymphatic Diseases (8) · Neoplasms by Histologic Type (8) · Neoplasms (7) · Hematologic Diseases (4) · Blood Protein Disorders (3) · Cardiovascular Diseases (3) · Hemorrhagic Disorders (3) · Hemostatic Disorders (3) · Lymphoma (3) · Lymphoma, Non-Hodgkin (3) · Neoplasms, Plasma Cell (3)
Adrenocorticotropic Hormone (1) · Buprenorphine, Naloxone Drug Combination (1) · Crizotinib (1) · Dexamethasone (1) · Donepezil (1) · Kyphoplasty (1) · Lenalidomide (1) · Meropenem (1) · Micafungin (1) · Prednisone (1) · R-CHOP protocol (1) · Valganciclovir (1) · Zoledronic Acid (1) · ixazomib (1) · pomalidomide (1)
Centre Hospitalier Universitaire, Amiens (1) · DFINE Inc. (1) · Eisai Inc. (1) · Jun Zhu (1) · Massachusetts General Hospital (1) · Novartis (1) · Ottawa Heart Institute Research Corporation (1) · Takeda (1) · The Cleveland Clinic (1) · University of Washington (1) · Wake Forest University Health Sciences (1)
United States (2) · Canada (1) · China (1) · France (1)
Corey Casper, MD, MPH (1) · Daniel Culver, DO (1) · David Birnie, MD (1) · Frank Vrionis, MD, MPH, PhD (1) · John Williamson, PharmD (1) · Jun Zhu, MD (1) · Pablo B. Nery, MD (1) · Thomas McRae (1) · Zhang Yi, MD PhD (1)